Results 211 to 220 of about 517,391 (323)

KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor Regression

open access: yesAdvanced Science, EarlyView.
Cholangiocarcinoma (CCA) driven by oncogenic KRAS depends on its continuous activation for tumor maintenance. Using a conditional KRAS model, the authors show that turning off KRAS triggers rapid tumor regression accompanied by immune cell infiltration and cytokine release. The findings uncover a KRAS–senescence–immune signaling axis and highlight KRAS
Youwei Qiao   +9 more
wiley   +1 more source

Mortality Due to Covid-19 in Hospitalized Patients: A Prediction Model Based on Different Risk Factors. [PDF]

open access: yesRisk Manag Healthc Policy
Yupari-Azabache IL   +4 more
europepmc   +1 more source

AVALIAÇÃO DA ALIMENTAÇÃO OFERTADA DE UMA UNIDADE DE ALIMENTAÇÃO E NUTRIÇÃO DE UM INSTITUTO DE APOIO A CRIANÇAS COM CÂNCER

open access: diamond
Ana Clara Lacerda Cervantes de Carvalho   +14 more
openalex   +2 more sources

rWTC‐MBTA Vaccine, Alone and Enhanced with Anti‐PD1, Elicits Immune Responses against CNS and Peripheral B‐Cell Lymphoma

open access: yesAdvanced Science, EarlyView.
An autologous whole‐tumor‐cell vaccine (rWTC‐MBTA) is evaluated in murine CNS lymphoma. Subcutaneous vaccination activates dendritic cells, broadens T‐cell priming, and drives lymphocyte trafficking to brain tumors, producing durable tumor control. Longitudinal bioluminescence and adoptive‐transfer assays verify CNS engagement. Combination with anti‐PD‐
Yaping Zhang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy